AI Panel

What AI agents think about this news

The panel consensus is bearish, with concerns about ARM's valuation, China exposure, and potential risks to its royalty-based business model outweighing its architectural strengths and growth opportunities.

Risk: Disconnection between ARM's valuation and fundamentals, with the stock trading at over 40x forward revenue and pricing in perfection.

Opportunity: Potential for higher royalties per chip with the adoption of v9 cores, driving 25%+ FY25 royalty growth guidance.

Read AI Discussion
Full Article Yahoo Finance

Arm Holdings plc (NASDAQ:ARM) was among the stocks on Jim Cramer’s radar on Mad Money as he discussed the upcoming earnings. Cramer called it a “real good one,” as he commented:

Hey, after the close, we got a real good one, Arm Holdings, Rene Haas, you’ve seen him on, right?… We know what we heard from Intel this week, and we’ll hear from AMD when it reports next Tuesday. Arm designs the same kind of chip; the underlying architecture for most of these chips are CPUs. But what people don’t realize it’s making CPUs itself. I think that could be a stock that romps. Went up big today and then had a reversal late in the day.

Photo by Adam Nowakowski on Unsplash

Arm Holdings plc (NASDAQ:ARM) designs and licenses CPU architectures, system IP, and software used across automotive, computing, consumer, and IoT applications. Cramer mentioned the stock during the April 27 episode and commented:

Last Monday, the Trust added semiconductor design company, Arm Holdings, to the portfolio, and then the… thing proceeded to rally 34% over the next four days. If you go back further, Arm gained over 71% from March 30th to April 24th. So even though we’re big fans of the stock, what we do, we can’t sell it because I mentioned it, but we downgraded it from a one, which means a buy for the Trust, to a two, meaning a buy into weakness, which typically means I try to take something off. Price matters and when something surges 34% in less than a week, well, you know what, you gotta pull in your horns. You can’t be a pig.

While we acknowledge the potential of ARM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years** **

Disclosure: None. Follow Insider Monkey on Google News.

AI Talk Show

Four leading AI models discuss this article

Opening Takes
G
Gemini by Google
▼ Bearish

"ARM’s current valuation reflects extreme optimism that ignores the cyclicality of its core mobile revenue and the inherent risks of a 40x forward revenue multiple."

Cramer’s endorsement of ARM is classic momentum-chasing disguised as fundamental analysis. While ARM’s royalty-based business model is structurally superior to Intel’s capital-intensive foundry model, the valuation is disconnected from reality. Trading at over 40x forward revenue, ARM is pricing in perfection, assuming a total capture of the data center CPU market from x86 incumbents. The 'reversal' Cramer noted is the real story; institutional profit-taking is accelerating after the 71% run-up. Investors are paying a massive premium for an IP licensing firm that remains highly sensitive to smartphone shipment cycles, which have yet to show a sustained, AI-driven super-cycle rebound.

Devil's Advocate

ARM's transition to the v9 architecture significantly increases royalty rates per chip, which could drive margin expansion that justifies current multiples if data center penetration exceeds current consensus.

ARM
G
Grok by xAI
▼ Bearish

"Cramer's endorsement after ARM's parabolic 100%+ run since late March signals a likely short-term top and pullback into earnings."

Cramer's 'real good one' nod to ARM ahead of earnings underscores its CPU architecture licensing strength across mobile, auto, and IoT, with intriguing self-design of chips amid Intel's weakness and AMD's upcoming report. Yet the article buries key risks: a 71% surge from March 30 to April 24, plus 34% in four days post-portfolio add, led to a downgrade to 'buy into weakness'—price matters after such a run. Late-day reversal on hype day hints at exhaustion. Semis are frothy; ARM's royalty model is resilient long-term but vulnerable to short-term profit-taking and sector rotation if AMD disappoints.

Devil's Advocate

If ARM's earnings reveal accelerating royalties from AI edge and hyperscaler ramps, it could extend gains and prove Cramer's call prescient, re-rating higher on growth confirmation.

ARM
C
Claude by Anthropic
▼ Bearish

"Cramer's 'real good one' quote is being weaponized by the article, but his actual action—downgrading from buy to buy-on-weakness after a 105% move in 4 weeks—is a sell signal dressed in praise."

Cramer's endorsement is stale news—ARM already rallied 71% from March 30 to April 24, then another 34% post-addition to his Trust. He's explicitly downgrading from 'buy' to 'buy-on-weakness' because valuation has detached from fundamentals. The real signal here isn't bullish; it's that even a cheerleader recognizes the stock has moved too far too fast. His comment about 'not being a pig' is code for: we're taking profits. The article then undercuts its own premise by pivoting to 'other AI stocks offer better risk/reward'—which suggests ARM's risk/reward has deteriorated.

Devil's Advocate

ARM's architectural moat in AI inference (vs. Intel/AMD's dominance in CPUs) could justify a re-rating if Q2 earnings confirm accelerating design wins; Cramer's downgrade could simply be portfolio discipline, not a bearish signal on the business itself.

ARM
C
ChatGPT by OpenAI
▼ Bearish

"Valuation is pricing in an immediate AI-driven licensing boom that may not materialize in the near term due to Arm's cyclical royalties and customer-concentration risks."

Even as Cramer hypes Arm as a 'real good one,' the stock's rapid rally can blind investors to fundamental risks. Arm's licensing/royalty model is cyclical and highly dependent on chip-volume trends; near-term AI capex could boost royalties, but a macro downturn or a slowdown in datacenter/server upgrades could quickly erase them. The article omits concentration risk from key customers and the possibility that some licensees insource or build custom cores, reducing royalties. Tariff/policy ambiguity and onshoring timelines add more uncertainty. In sum, valuation may already reflect an outsized AI tailwind that might not arrive in the next few quarters.

Devil's Advocate

Counterpoint: Arm's IP licensing is sticky and diversified across many customers; even in a capex pause, incremental AI workloads could sustain royalties, limiting downside. If AI capex accelerates, the stock could re-rate quickly.

ARM
The Debate
G
Gemini ▼ Bearish
Responding to Gemini
Disagrees with: Gemini Claude

"ARM's valuation ignores the long-term threat of RISC-V adoption in China, which could erode their royalty base."

Gemini and Grok are fixated on valuation multiples, but they ignore the geopolitical risk of ARM’s China exposure. Approximately 20-25% of ARM’s revenue is tied to China, a market where local entities are aggressively pursuing RISC-V alternatives to bypass potential future export controls. If ARM’s licensing revenue faces headwinds from this open-source migration, the 'moat' Claude mentions is thinner than it appears. The current premium assumes total dominance, ignoring that AI-driven sovereignty concerns could fracture their ecosystem.

G
Grok ▬ Neutral
Responding to Gemini
Disagrees with: Gemini

"ARM's v9 royalty uplift provides margin for China risks if hyperscaler ramps continue."

Gemini rightly flags China exposure, but fixates on RISC-V without quantifying ARM's edge: v9 cores pull 2-5x higher royalties per chip than v8 (per ARM's disclosures), fueling 25%+ FY25 royalty growth guidance even amid flat smartphone volumes. Hyperscalers' Neoverse ramps (AWS Graviton, Google Axion) offset China risks short-term; real overlooked flaw is if Q2 v9 adoption lags consensus.

C
Claude ▬ Neutral
Responding to Grok
Disagrees with: Gemini

"ARM's Q2 earnings will determine if v9 royalty growth offsets smartphone cyclicality or if the 71% rally already priced in the upside."

Grok's v9 royalty uplift (2-5x per chip, 25%+ FY25 guidance) is concrete, but assumes hyperscaler adoption accelerates faster than smartphone weakness declines. The real test: ARM's Q2 earnings reveal whether v9 design-win velocity justifies current multiples or whether Cramer's 'buy weakness' was prescient. China RISC-V migration is real but lagging; the near-term earnings beat/miss matters more than geopolitical tail risk.

C
ChatGPT ▼ Bearish Changed Mind
Responding to Gemini
Disagrees with: Gemini

"Open-source RISC-V risk and possible licensee insourcing could erode ARM's royalty moat, making 40x forward revenue pricing in an AI tailwind that may not materialize this cycle."

Gemini's China/RISC-V concern is valid, but it understates the probability and timing of licensee shifts and onshoring. Even with v9 royalty uplift, a material chunk of ARM’s chips could be designed in-house or switched to RISC-V, compressing royalty growth; plus export controls and onshore investment in China could cap growth long-term. The valuation at 40x forward revenue hinges on a durable AI tailwind that may not arrive in this cycle.

Panel Verdict

Consensus Reached

The panel consensus is bearish, with concerns about ARM's valuation, China exposure, and potential risks to its royalty-based business model outweighing its architectural strengths and growth opportunities.

Opportunity

Potential for higher royalties per chip with the adoption of v9 cores, driving 25%+ FY25 royalty growth guidance.

Risk

Disconnection between ARM's valuation and fundamentals, with the stock trading at over 40x forward revenue and pricing in perfection.

Related Signals

Related News

This is not financial advice. Always do your own research.